Driving reinvestment in R&D for antibiotics and advocating their responsible use

Category Archives: News

DRIVE-AB Policy Brief – A Pan-EU-EEA Pull Incentive for Antimicrobial Innovation and Access

DRIVE-AB Policy brief on a Pan-EU-EEA Pull Incentive for Antimicrobial Innovation and Access Academic experts in the area of antimicrobial pull incentives, are excited to see the Council Recommendation from June 2023 regarding European Union (EU) actions to combat antimicrobial resistance (AMR) in a One Health approach, Access policy document...
Read moreComments are closed

DRIVE-AB final conference_Overview and materials

The final DRIVE-AB conference, “Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access”, was held at the Crowne Plaza Le Palace in Brussels, Belgium, on 5-6 September 2017. The conference attracted approximately 200 participants from a wide range of stakeholder groups, including policy-makers, medical professionals, representatives of the pharmaceutical and biotechnology industries, civil society communities, and regulatory and public health experts. The day and a half conference was focused on the communication of the consortium’s research results and recommended options to drive investment in antibiotics that included a combination of incentive mechanisms along with finance and governance options to support their implementation. These presentations...
Read moreComments are closed

Revitalizing the Antibiotic Pipeline: DRIVE-AB Conference Speakers Announced

The speakers and panelists for the upcoming DRIVE-AB conference, Revitalizing the Antibiotic Pipeline, have now been announced. With representatives from a variety of stakeholder groups including the World Health Organization, the European Investment Bank, the European Commission, and various national Ministries and Departments of Health, among others, the discussions are expected to be robust, informative, and productive. The conference will take place on 5-6 September 2017 at the Crowne Plaza in Brussels. Aimed at global policy and decision makers, regulatory and public health experts, economists and representatives of the pharmaceutical, medical and civil society communities, the purpose of the conference is to:
  1. communicate the consortium’s final recommendations...
Read moreComments are closed

UN Interagency Coordination Group on AMR Opens Online Consultation On Draft Work Plan

The UN Secretary-General’s Interagency Coordination Group on Antimicrobial Resistance (IACG), whose establishment was mandated by the a UN General Assembly Resolution in 2016 calling for an ad hoc interagency coordination group to provide guidance on ensuring effective global action on AMR, is now inviting comments on the draft work plan for 2017-2019. The IACG’s first face-to-face meeting was held 2-3 May 2017 at UN Headquarters in New York. A second meeting was held by teleconference on 30 June 2017 to discuss the group’s work plan for 2017-2019. The work plan is now available on the WHO website for consultation and stakeholders...
Read moreComments are closed